Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.DexCom, a medical device company, has closed its previously announced public offering of 15.84 million shares of its common stock at a price of $3 per share.
Subscribe to our email newsletter
In addition, Terrance Gregg, DexCom’s president and CEO, also purchased 150,000 additional shares of common stock in this offering at a per share price of $3.12, which represents the last reported bid price on the NASDAQ global market of DexCom’s common stock on January 29, 2009.
The gross proceeds to DexCom, before expenses, from the sale of the shares were $48 million. Piper Jaffray & Co acted as sole manager for the offering.